An ompR-envZ Two-Component System Ortholog Regulates Phase Variation, Osmotic Tolerance, Motility, and Virulence in Acinetobacter baumannii Strain AB5075
Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colon...
Saved in:
Published in | Journal of bacteriology Vol. 199; no. 3; p. E00705 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
01.02.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Recently, a novel phase-variable colony opacity phenotype was discovered in
Acinetobacter baumannii
strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator
ompR
. Subsequent investigation of in-frame deletions of
ompR
and the sensor kinase
envZ
(located adjacent to
ompR
) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The
ompR
mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the
envZ
mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in
A. baumannii
strain AB5075, but a mutation in both
ompR
and
envZ
produced a more profound effect. The
ompR
and
envZ
genes were cotranscribed but were not subject to autoregulation by OmpR. Both
ompR
and
envZ
mutant opaque variants were attenuated in virulence in the
Galleria mellonella
infection model, whereas mutation of
ompR
had no effect on the virulence of the translucent variant.
IMPORTANCE
Acinetobacter baumannii
is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of
Acinetobacter
infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in
A. baumannii
, this may represent an “Achilles' heel” that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The
ompR-envZ
two-component system ortholog negatively regulates phase variation in
A. baumannii
, and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model. |
---|---|
AbstractList | Recently, a novel phase-variable colony opacity phenotype was discovered in
Acinetobacter baumannii
strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator
ompR
. Subsequent investigation of in-frame deletions of
ompR
and the sensor kinase
envZ
(located adjacent to
ompR
) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The
ompR
mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the
envZ
mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in
A. baumannii
strain AB5075, but a mutation in both
ompR
and
envZ
produced a more profound effect. The
ompR
and
envZ
genes were cotranscribed but were not subject to autoregulation by OmpR. Both
ompR
and
envZ
mutant opaque variants were attenuated in virulence in the
Galleria mellonella
infection model, whereas mutation of
ompR
had no effect on the virulence of the translucent variant.
IMPORTANCE
Acinetobacter baumannii
is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of
Acinetobacter
infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in
A. baumannii
, this may represent an “Achilles' heel” that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The
ompR-envZ
two-component system ortholog negatively regulates phase variation in
A. baumannii
, and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model. Recently, a novel phase-variable colony opacity phenotype was discovered in strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator Subsequent investigation of in-frame deletions of and the sensor kinase (located adjacent to ) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in strain AB5075, but a mutation in both and produced a more profound effect. The and genes were cotranscribed but were not subject to autoregulation by OmpR. Both and mutant opaque variants were attenuated in virulence in the infection model, whereas mutation of had no effect on the virulence of the translucent variant. is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in , this may represent an "Achilles' heel" that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The two-component system ortholog negatively regulates phase variation in , and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model. Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR. Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant. IMPORTANCE Acinetobacter baumannii is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of Acinetobacter infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in A. baumannii, this may represent an "Achilles' heel" that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The ompR-envZ two-component system ortholog negatively regulates phase variation in A. baumannii, and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model. Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant. IMPORTANCEAcinetobacter baumannii is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of Acinetobacter infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in A. baumannii, this may represent an "Achilles' heel" that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The ompR-envZ two-component system ortholog negatively regulates phase variation in A. baumannii, and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model.Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant. IMPORTANCEAcinetobacter baumannii is a well-known antibiotic-resistant pathogen; many clinical isolates can only be treated by a very small number of antibiotics (including colistin), while some exhibit panresistance. The current antimicrobial arsenal is nearing futility in the treatment of Acinetobacter infections, and new avenues of treatment are profoundly needed. Since phase variation controls the transition between opaque (virulent) and translucent (avirulent) states in A. baumannii, this may represent an "Achilles' heel" that can be targeted via the development of small molecules that lock cells in the translucent state and allow the host immune system to clear the infection. A better understanding of how phase variation is regulated may allow for the development of methods to target this process. The ompR-envZ two-component system ortholog negatively regulates phase variation in A. baumannii, and perturbation of this system leads to the attenuation of virulence in an invertebrate infection model. Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque and translucent variants. Opaque colonies become mottled or sectored after 24 h of growth due to translucent variants arising within the colony. This easily distinguishable opaque-colony phenotype was used to screen for random transposon insertions that increased the frequency of sectoring at a time point when wild-type colonies were uniformly opaque. A colony was identified that contained multiple papillae of translucent variants, and the insertion in this mutant mapped to an ortholog of the two-component system response regulator ompR. Subsequent investigation of in-frame deletions of ompR and the sensor kinase envZ (located adjacent to ompR) showed that the switching frequency from opaque to translucent was increased 401- and 281-fold, respectively. The ompR mutant also exhibited sensitivity to sodium chloride in growth medium, whereas the envZ mutation did not elicit sensitivity to sodium chloride. Mutation of either gene reduced motility in A. baumannii strain AB5075, but a mutation in both ompR and envZ produced a more profound effect. The ompR and envZ genes were cotranscribed but were not subject to autoregulation by OmpR. Both ompR and envZ mutant opaque variants were attenuated in virulence in the Galleria mellonella infection model, whereas mutation of ompR had no effect on the virulence of the translucent variant. |
Author | Rather, Philip N. Tipton, Kyle A. |
Author_xml | – sequence: 1 givenname: Kyle A. surname: Tipton fullname: Tipton, Kyle A. organization: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA – sequence: 2 givenname: Philip N. surname: Rather fullname: Rather, Philip N. organization: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA, Research Service, Atlanta VA Medical Center, Decatur, Georgia, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27872182$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkk1v1DAQhi1URLcLJ-7IEhckmmI7ceJckHZXfFVFi9qlBy6W40x2XSX2YjtF-1P4t3jbUkHFAV8szzx-57VnjtCBdRYQek7JCaVMvDmdnxBSEZ7R8hGaUFKLjPOcHKAJIYxmNa3zQ3QUwhUhtCg4e4IOWSUqRgWboJ8zi92wPc_AXn_Dqx8uW6RjKmAjvtiFCANe-rhxvVvjc1iPvYoQ8JeNCoAvlTcqGmeP8TIMLhqNV64Hr6yGY_w5BXoTd8dY2RZfGj_2kBLYWDzTxkJ0jdIRPG7UOChrjcEX0at9es5JxZ-ix53qAzy726fo6_t3q8XH7Gz54dNidpbpvGIx0yxvupwXLSeqaUnBuFCc5Zy0KldlB5VuVVnRrqtJATk0rKwF1JRWtBG1EHU-RW9vdbdjM0Cr08u96uXWm0H5nXTKyL8z1mzk2l3LVKWitEgCr-4EvPs-QohyMEFD3ysLbgySilLkaYn_QZP_ui5JmdCXD9ArN3qbfmIvSIigPBmYohd_mr93_bvBCXh9C2jvQvDQ3SOUyP34yNO5vBkfSfdF6QNam3jT4n1n-n_e-QUuAcdq |
CODEN | JOBAAY |
CitedBy_id | crossref_primary_10_1111_1462_2920_14565 crossref_primary_10_3389_fcimb_2023_1053968 crossref_primary_10_1016_j_micpath_2018_12_039 crossref_primary_10_3390_ijms25073862 crossref_primary_10_3389_fmicb_2018_02459 crossref_primary_10_3390_antibiotics9030119 crossref_primary_10_1038_s42003_024_05995_z crossref_primary_10_3389_fmicb_2020_00548 crossref_primary_10_1016_j_aquaculture_2022_738441 crossref_primary_10_3390_microorganisms8071068 crossref_primary_10_1016_j_celrep_2021_108920 crossref_primary_10_3389_fcimb_2023_1203487 crossref_primary_10_1128_iai_00023_23 crossref_primary_10_3389_fmicb_2021_764733 crossref_primary_10_1128_aac_01033_22 crossref_primary_10_3389_fmicb_2022_1032969 crossref_primary_10_1111_1758_2229_12718 crossref_primary_10_3389_fmicb_2021_653556 crossref_primary_10_2147_IDR_S380883 crossref_primary_10_1038_s41598_020_71672_w crossref_primary_10_3390_pathogens10111483 crossref_primary_10_3390_biom10050720 crossref_primary_10_1016_j_micres_2019_126295 crossref_primary_10_1080_21505594_2022_2135273 crossref_primary_10_1007_s00203_021_02721_9 crossref_primary_10_3389_fmicb_2018_02405 crossref_primary_10_2174_2772434417666220912120726 crossref_primary_10_1080_21505594_2021_1980987 crossref_primary_10_1038_s41396_021_01179_3 crossref_primary_10_1128_aac_01102_23 crossref_primary_10_21307_PM_2020_59_3_19 crossref_primary_10_1007_s00232_018_0014_2 crossref_primary_10_3390_microorganisms8111793 crossref_primary_10_3389_fmicb_2018_03301 crossref_primary_10_1016_j_aquaculture_2023_739718 crossref_primary_10_3390_ijms20071781 crossref_primary_10_1128_IAI_00912_19 crossref_primary_10_1128_spectrum_02145_21 crossref_primary_10_3389_fmicb_2023_1139253 crossref_primary_10_1016_j_gene_2022_146295 crossref_primary_10_2174_0118715257267497231128093529 crossref_primary_10_2217_fmb_2019_0002 crossref_primary_10_3389_fmicb_2022_1041146 crossref_primary_10_1038_s41522_020_00178_0 crossref_primary_10_1128_spectrum_02311_22 crossref_primary_10_3389_fmicb_2021_705853 crossref_primary_10_1071_MA17046 crossref_primary_10_1016_j_micres_2022_127057 crossref_primary_10_3389_fcimb_2017_00055 crossref_primary_10_1016_j_aquaculture_2025_742258 crossref_primary_10_1038_nrmicro_2017_148 crossref_primary_10_1016_j_micres_2021_126722 crossref_primary_10_1016_j_crmicr_2024_100331 crossref_primary_10_1007_s00284_021_02407_x crossref_primary_10_1038_s41564_018_0151_5 crossref_primary_10_1128_mBio_02338_20 crossref_primary_10_1371_journal_ppat_1008439 crossref_primary_10_1016_j_psj_2022_102388 crossref_primary_10_1128_msystems_00606_23 crossref_primary_10_3389_fmicb_2022_885092 crossref_primary_10_1080_21505594_2021_1950268 crossref_primary_10_1007_s44372_025_00092_9 crossref_primary_10_1128_AAC_01188_18 crossref_primary_10_1146_annurev_micro_020518_115714 crossref_primary_10_1128_JB_00565_20 crossref_primary_10_1128_IAI_00141_20 crossref_primary_10_1002_mbo3_1041 |
Cites_doi | 10.1099/mic.0.026187-0 10.1093/infdis/jiu274 10.1128/mBio.01076-14 10.1046/j.1365-2958.2002.03170.x 10.1128/AAC.42.7.1529 10.1128/JB.186.20.6689-6697.2004 10.1128/iai.57.7.2136-2140.1989 10.1016/j.str.2015.12.009 10.1146/annurev.genet.41.042007.170548 10.1128/AAC.01132-06 10.1006/jmbi.1998.1985 10.1128/JB.00817-08 10.1128/JB.180.9.2442-2449.1998 10.1128/jb.172.11.6274-6281.1990 10.1128/jb.177.16.4696-4702.1995 10.1128/AAC.01433-06 10.1111/j.1574-6968.2011.02362.x 10.1126/science.1160354 10.1001/jama.2009.1754 10.1128/jb.147.1.255-258.1981 10.1097/CCM.0000000000000125 10.1093/nar/29.10.2003 10.1128/JB.01780-05 10.1038/nprot.2006.24 10.1128/jb.170.12.5971-5973.1988 10.1016/S0378-1119(98)00130-9 10.1146/annurev.biochem.69.1.183 10.1099/mic.0.049791-0 10.1128/AAC.03626-14 10.1128/IAI.02034-14 10.1073/pnas.83.20.7850 10.1128/JB.00917-10 10.1007/s12275-012-1555-1 10.1128/JB.00188-15 10.1016/0378-1119(90)90494-C 10.1086/533452 10.1111/j.1365-2958.1990.tb00681.x 10.1128/JCM.36.7.1938-1941.1998 10.1111/j.1574-6968.1980.tb05614.x 10.1016/j.febslet.2007.10.063 10.1016/j.ijantimicag.2015.03.001 10.3389/fmicb.2012.00148 10.1016/j.ijmm.2012.03.003 |
ContentType | Journal Article |
Copyright | Copyright © 2017 American Society for Microbiology. Copyright American Society for Microbiology Feb 2017 Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2017 American Society for Microbiology. – notice: Copyright American Society for Microbiology Feb 2017 – notice: Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology |
DBID | AAYXX CITATION NPM 7QL 7TM 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
DOI | 10.1128/JB.00705-16 |
DatabaseName | CrossRef PubMed Bacteriology Abstracts (Microbiology B) Nucleic Acids Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Genetics Abstracts Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed Bacteriology Abstracts (Microbiology B) MEDLINE - Academic Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | TCS Regulates Phase Variation in A. baumannii |
EISSN | 1098-5530 |
ExternalDocumentID | PMC5237114 4305027231 27872182 10_1128_JB_00705_16 |
Genre | Journal Article Feature |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R21 AI115183 – fundername: HHS | National Institutes of Health (NIH) grantid: R21AI115183 |
GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 186 18M 1VV 29J 2WC 39C 3O- 4.4 53G 5GY 5RE 5VS 79B 85S 8WZ 9M8 A6W AAGFI AAYXX ABPPZ ACGFO ACGOD ACNCT ACPRK ADBBV ADXHL AENEX AFFDN AFFNX AFRAH AGCDD AGVNZ AI. AIDAL AJUXI ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BKOMP BTFSW C1A CITATION CJ0 CS3 DIK DU5 E3Z EBS EJD F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 L7B MVM NHB O9- OHT OK1 P-O P-S P2P PQQKQ QZG RHI RNS RPM RSF RXW TAE TR2 UHB UKR UPT VH1 W8F WH7 WHG WOQ X7M Y6R YQT YR2 YZZ ZCA ZCG ZGI ZXP ZY4 ~02 ~KM NPM RHF UCJ VQA YIN 7QL 7TM 7U9 8FD C1K FR3 H94 M7N P64 RC3 7X8 5PM |
ID | FETCH-LOGICAL-c372t-c23bf354d50abd04258a52350da3a6fe7cda671ff904e3eb2698e91171b898893 |
ISSN | 0021-9193 1098-5530 |
IngestDate | Thu Aug 21 14:07:49 EDT 2025 Fri Jul 11 08:41:53 EDT 2025 Fri Jul 11 12:12:48 EDT 2025 Mon Jun 30 08:15:15 EDT 2025 Wed Feb 19 02:43:32 EST 2025 Thu Apr 24 22:59:22 EDT 2025 Tue Jul 01 02:56:23 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | osmotic stress Acinetobacter phase variation |
Language | English |
License | Copyright © 2017 American Society for Microbiology. All Rights Reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c372t-c23bf354d50abd04258a52350da3a6fe7cda671ff904e3eb2698e91171b898893 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 Citation Tipton KA, Rather PN. 2017. An ompR-envZ two-component system ortholog regulates phase variation, osmotic tolerance, motility, and virulence in Acinetobacter baumannii strain AB5075. J Bacteriol 199:e00705-16. https://doi.org/10.1128/JB.00705-16. |
OpenAccessLink | https://jb.asm.org/content/jb/199/3/e00705-16.full.pdf |
PMID | 27872182 |
PQID | 1860081552 |
PQPubID | 40724 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5237114 proquest_miscellaneous_1868333384 proquest_miscellaneous_1842599606 proquest_journals_1860081552 pubmed_primary_27872182 crossref_primary_10_1128_JB_00705_16 crossref_citationtrail_10_1128_JB_00705_16 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-02-01 |
PublicationDateYYYYMMDD | 2017-02-01 |
PublicationDate_xml | – month: 02 year: 2017 text: 2017-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of bacteriology |
PublicationTitleAlternate | J Bacteriol |
PublicationYear | 2017 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_3_17_2 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_38_2 e_1_3_3_18_2 e_1_3_3_39_2 e_1_3_3_13_2 e_1_3_3_36_2 Centers for Disease Control and Prevention (e_1_3_3_4_2) 2004; 53 e_1_3_3_12_2 e_1_3_3_37_2 e_1_3_3_15_2 e_1_3_3_34_2 e_1_3_3_14_2 e_1_3_3_35_2 e_1_3_3_32_2 e_1_3_3_33_2 e_1_3_3_11_2 e_1_3_3_30_2 e_1_3_3_10_2 e_1_3_3_31_2 e_1_3_3_40_2 e_1_3_3_6_2 e_1_3_3_5_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_45_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_43_2 e_1_3_3_44_2 e_1_3_3_22_2 e_1_3_3_41_2 e_1_3_3_3_2 e_1_3_3_21_2 e_1_3_3_42_2 17576842 - Antimicrob Agents Chemother. 2007 Sep;51(9):3431-3 17220422 - Antimicrob Agents Chemother. 2007 Apr;51(4):1530-3 9719640 - J Mol Biol. 1998 Sep 4;281(5):857-70 24813471 - J Infect Dis. 2014 Nov 1;210(9):1367-75 22752907 - J Microbiol. 2012 Jun;50(3):434-43 2121709 - J Bacteriol. 1990 Nov;172(11):6274-81 18076326 - Annu Rev Genet. 2007;41:121-45 25857949 - Int J Antimicrob Agents. 2015 Jun;45(6):568-85 11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45 17406227 - Nat Protoc. 2006;1(1):153-61 19952319 - JAMA. 2009 Dec 2;302(21):2323-9 26013481 - J Bacteriol. 2015 Aug 1;197(15):2593-9 25156738 - Infect Immun. 2014 Nov;82(11):4666-80 24394630 - Crit Care Med. 2014 May;42(5):1081-8 10966457 - Annu Rev Biochem. 2000;69:183-215 6263866 - J Bacteriol. 1981 Jul;147(1):255-8 22560766 - Int J Med Microbiol. 2012 Jul;302(3):117-28 17997983 - FEBS Lett. 2007 Dec 11;581(29):5573-8 24865555 - MBio. 2014 May 27;5(3):e01076-14 19383700 - Microbiology. 2009 Jun;155(Pt 6):1832-9 9661666 - Gene. 1998 May 28;212(1):77-86 25512405 - Antimicrob Agents Chemother. 2015 Feb;59(2):1236-45 2543631 - Infect Immun. 1989 Jul;57(7):2136-40 9650940 - J Clin Microbiol. 1998 Jul;36(7):1938-41 15466019 - J Bacteriol. 2004 Oct;186(20):6689-97 15549020 - MMWR Morb Mortal Wkly Rep. 2004 Nov 19;53(45):1063-6 22092679 - FEMS Microbiol Lett. 2011 Oct;323(1):44-51 16707665 - J Bacteriol. 2006 Jun;188(11):3731-9 20889755 - J Bacteriol. 2010 Dec;192(24):6336-45 1700256 - Mol Microbiol. 1990 Jul;4(7):1077-82 3020561 - Proc Natl Acad Sci U S A. 1986 Oct;83(20):7850-4 2185139 - Gene. 1990 Mar 1;87(1):45-51 26805524 - Structure. 2016 Feb 2;24(2):221-31 9573197 - J Bacteriol. 1998 May;180(9):2442-9 22536199 - Front Microbiol. 2012 Apr 23;3:148 9660978 - Antimicrob Agents Chemother. 1998 Jul;42(7):1529-36 18419525 - J Infect Dis. 2008 Apr 15;197(8):1079-81 3056929 - J Bacteriol. 1988 Dec;170(12):5971-3 19201803 - J Bacteriol. 2009 Apr;191(8):2834-42 7642497 - J Bacteriol. 1995 Aug;177(16):4696-702 21700662 - Microbiology. 2011 Sep;157(Pt 9):2534-44 12366850 - Mol Microbiol. 2002 Oct;46(1):281-91 18719281 - Science. 2008 Aug 22;321(5892):1078-80 |
References_xml | – ident: e_1_3_3_19_2 doi: 10.1099/mic.0.026187-0 – ident: e_1_3_3_22_2 doi: 10.1093/infdis/jiu274 – ident: e_1_3_3_45_2 doi: 10.1128/mBio.01076-14 – ident: e_1_3_3_18_2 doi: 10.1046/j.1365-2958.2002.03170.x – ident: e_1_3_3_40_2 doi: 10.1128/AAC.42.7.1529 – ident: e_1_3_3_36_2 doi: 10.1128/JB.186.20.6689-6697.2004 – ident: e_1_3_3_20_2 doi: 10.1128/iai.57.7.2136-2140.1989 – ident: e_1_3_3_32_2 doi: 10.1016/j.str.2015.12.009 – ident: e_1_3_3_13_2 doi: 10.1146/annurev.genet.41.042007.170548 – ident: e_1_3_3_9_2 doi: 10.1128/AAC.01132-06 – ident: e_1_3_3_39_2 doi: 10.1006/jmbi.1998.1985 – ident: e_1_3_3_38_2 doi: 10.1128/JB.00817-08 – ident: e_1_3_3_30_2 doi: 10.1128/JB.180.9.2442-2449.1998 – ident: e_1_3_3_21_2 doi: 10.1128/jb.172.11.6274-6281.1990 – ident: e_1_3_3_24_2 doi: 10.1128/jb.177.16.4696-4702.1995 – ident: e_1_3_3_8_2 doi: 10.1128/AAC.01433-06 – volume: 53 start-page: 1063 year: 2004 ident: e_1_3_3_4_2 article-title: Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004 publication-title: Morb Mortal Wkly Rep – ident: e_1_3_3_27_2 doi: 10.1111/j.1574-6968.2011.02362.x – ident: e_1_3_3_41_2 doi: 10.1126/science.1160354 – ident: e_1_3_3_7_2 doi: 10.1001/jama.2009.1754 – ident: e_1_3_3_15_2 doi: 10.1128/jb.147.1.255-258.1981 – ident: e_1_3_3_10_2 doi: 10.1097/CCM.0000000000000125 – ident: e_1_3_3_44_2 doi: 10.1093/nar/29.10.2003 – ident: e_1_3_3_31_2 doi: 10.1128/JB.01780-05 – ident: e_1_3_3_43_2 doi: 10.1038/nprot.2006.24 – ident: e_1_3_3_17_2 doi: 10.1128/jb.170.12.5971-5973.1988 – ident: e_1_3_3_42_2 doi: 10.1016/S0378-1119(98)00130-9 – ident: e_1_3_3_12_2 doi: 10.1146/annurev.biochem.69.1.183 – ident: e_1_3_3_26_2 doi: 10.1099/mic.0.049791-0 – ident: e_1_3_3_35_2 doi: 10.1128/AAC.03626-14 – ident: e_1_3_3_34_2 doi: 10.1128/IAI.02034-14 – ident: e_1_3_3_16_2 doi: 10.1073/pnas.83.20.7850 – ident: e_1_3_3_25_2 doi: 10.1128/JB.00917-10 – ident: e_1_3_3_28_2 doi: 10.1007/s12275-012-1555-1 – ident: e_1_3_3_11_2 doi: 10.1128/JB.00188-15 – ident: e_1_3_3_23_2 doi: 10.1016/0378-1119(90)90494-C – ident: e_1_3_3_2_2 doi: 10.1086/533452 – ident: e_1_3_3_14_2 doi: 10.1111/j.1365-2958.1990.tb00681.x – ident: e_1_3_3_5_2 doi: 10.1128/JCM.36.7.1938-1941.1998 – ident: e_1_3_3_37_2 doi: 10.1111/j.1574-6968.1980.tb05614.x – ident: e_1_3_3_33_2 doi: 10.1016/j.febslet.2007.10.063 – ident: e_1_3_3_3_2 doi: 10.1016/j.ijantimicag.2015.03.001 – ident: e_1_3_3_6_2 doi: 10.3389/fmicb.2012.00148 – ident: e_1_3_3_29_2 doi: 10.1016/j.ijmm.2012.03.003 – reference: 9660978 - Antimicrob Agents Chemother. 1998 Jul;42(7):1529-36 – reference: 2121709 - J Bacteriol. 1990 Nov;172(11):6274-81 – reference: 22092679 - FEMS Microbiol Lett. 2011 Oct;323(1):44-51 – reference: 7642497 - J Bacteriol. 1995 Aug;177(16):4696-702 – reference: 9650940 - J Clin Microbiol. 1998 Jul;36(7):1938-41 – reference: 24865555 - MBio. 2014 May 27;5(3):e01076-14 – reference: 17576842 - Antimicrob Agents Chemother. 2007 Sep;51(9):3431-3 – reference: 26805524 - Structure. 2016 Feb 2;24(2):221-31 – reference: 19383700 - Microbiology. 2009 Jun;155(Pt 6):1832-9 – reference: 25512405 - Antimicrob Agents Chemother. 2015 Feb;59(2):1236-45 – reference: 22752907 - J Microbiol. 2012 Jun;50(3):434-43 – reference: 24394630 - Crit Care Med. 2014 May;42(5):1081-8 – reference: 26013481 - J Bacteriol. 2015 Aug 1;197(15):2593-9 – reference: 3056929 - J Bacteriol. 1988 Dec;170(12):5971-3 – reference: 25857949 - Int J Antimicrob Agents. 2015 Jun;45(6):568-85 – reference: 18419525 - J Infect Dis. 2008 Apr 15;197(8):1079-81 – reference: 15549020 - MMWR Morb Mortal Wkly Rep. 2004 Nov 19;53(45):1063-6 – reference: 19952319 - JAMA. 2009 Dec 2;302(21):2323-9 – reference: 20889755 - J Bacteriol. 2010 Dec;192(24):6336-45 – reference: 9661666 - Gene. 1998 May 28;212(1):77-86 – reference: 10966457 - Annu Rev Biochem. 2000;69:183-215 – reference: 12366850 - Mol Microbiol. 2002 Oct;46(1):281-91 – reference: 18719281 - Science. 2008 Aug 22;321(5892):1078-80 – reference: 22536199 - Front Microbiol. 2012 Apr 23;3:148 – reference: 6263866 - J Bacteriol. 1981 Jul;147(1):255-8 – reference: 17406227 - Nat Protoc. 2006;1(1):153-61 – reference: 16707665 - J Bacteriol. 2006 Jun;188(11):3731-9 – reference: 1700256 - Mol Microbiol. 1990 Jul;4(7):1077-82 – reference: 15466019 - J Bacteriol. 2004 Oct;186(20):6689-97 – reference: 2185139 - Gene. 1990 Mar 1;87(1):45-51 – reference: 11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45 – reference: 24813471 - J Infect Dis. 2014 Nov 1;210(9):1367-75 – reference: 25156738 - Infect Immun. 2014 Nov;82(11):4666-80 – reference: 17997983 - FEBS Lett. 2007 Dec 11;581(29):5573-8 – reference: 21700662 - Microbiology. 2011 Sep;157(Pt 9):2534-44 – reference: 2543631 - Infect Immun. 1989 Jul;57(7):2136-40 – reference: 19201803 - J Bacteriol. 2009 Apr;191(8):2834-42 – reference: 17220422 - Antimicrob Agents Chemother. 2007 Apr;51(4):1530-3 – reference: 22560766 - Int J Med Microbiol. 2012 Jul;302(3):117-28 – reference: 3020561 - Proc Natl Acad Sci U S A. 1986 Oct;83(20):7850-4 – reference: 9719640 - J Mol Biol. 1998 Sep 4;281(5):857-70 – reference: 9573197 - J Bacteriol. 1998 May;180(9):2442-9 – reference: 18076326 - Annu Rev Genet. 2007;41:121-45 |
SSID | ssj0014452 |
Score | 2.498303 |
Snippet | Recently, a novel phase-variable colony opacity phenotype was discovered in
Acinetobacter baumannii
strain AB5075, where colonies interconvert between opaque... Recently, a novel phase-variable colony opacity phenotype was discovered in strain AB5075, where colonies interconvert between opaque and translucent variants.... Recently, a novel phase-variable colony opacity phenotype was discovered in Acinetobacter baumannii strain AB5075, where colonies interconvert between opaque... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | E00705 |
SubjectTerms | Acinetobacter Acinetobacter baumannii Bacteriology Galleria mellonella Genotype & phenotype Gram-negative bacteria Kinases Motility Mutation Opacity Osmosis Protein folding Sodium chloride |
Title | An ompR-envZ Two-Component System Ortholog Regulates Phase Variation, Osmotic Tolerance, Motility, and Virulence in Acinetobacter baumannii Strain AB5075 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27872182 https://www.proquest.com/docview/1860081552 https://www.proquest.com/docview/1842599606 https://www.proquest.com/docview/1868333384 https://pubmed.ncbi.nlm.nih.gov/PMC5237114 |
Volume | 199 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELdgCIkXxP8VBjLSnkgDiRM7zmOLQFMRDE3dVPESOYmrRerSqmtB45vwbbmzE7eBDgF9iCrbSRzfz-e7s--OkEM1DYpYCukHJWd-LDHNixS5r2PNteSsTFP0d_74SRydxqMJn2zOqhrvklX-uvi-06_kf6gKZUBX9JL9B8q6h0IB_Af6whUoDNe_ovEAZL2LxYmv669fvPG3uY-ze17j9r6NRO4dL1eGvcEwmpzz-tL7fA4Ll3cGOrI92AFjfGyS-RTeeD7TmGjDWquhaNbkDEDr-lm1XBsPJWMiwf145AUY69nLFW4F1FWFm9wKq4cgAPJrBF97U9Wx54-Bddm-fLia6Y2B9cQIqBvLT7Nz1JgpYOkL3JEPbVkrRi7FJEUd3muzIzUgi3bzdIZ-CqMhRjnHsKliuxUQZHFhyMuA9WA4-s3C5o4btlU3yS0G2oTxCZ-4k0CgUnLWuG7Cu95svQlDRTf3duWW35SRX8_Ubgkp43vkbjPIdGChcp_c0PUDctvmG716SH4MauoAQzuAoRYwtAUMdYChBjDUAaZPG7hQB5c-bcHSpwAV6qBCq5p2oEIdVKiFCrVQeURO378bvz3ym9wcfhElbOUXLMqnEY9LHqi8RM4vFWcRD0oVKTHVSVEqkYTTaRrEOtI5E6nUsLAmYS5TCULyY7JXw_ftEwoaPugBRR4qieKlzKVSOoolLA4h5o_skVftyGdFE7geezjLjALLZDYaZoZiWSh65NA1Xth4LbubHbQkzJoJfZmFUqCEzDnrkZeuGtgt7qGpWs_X2AY-FSMaiT-1ETKCn4x75IlFhetLC6ceSTp4cQ0w3Hu3pq7OTdh3GN4kDOOn1z7zGbmzmXkHZG-1XOvnIDKv8hcG8D8BTirCbA |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+ompR-envZ+Two-Component+System+Ortholog+Regulates+Phase+Variation%2C+Osmotic+Tolerance%2C+Motility%2C+and+Virulence+in+Acinetobacter+baumannii+Strain+AB5075&rft.jtitle=Journal+of+bacteriology&rft.au=Tipton%2C+Kyle+A&rft.au=Rather%2C+Philip+N&rft.date=2017-02-01&rft.eissn=1098-5530&rft.volume=199&rft.issue=3&rft_id=info:doi/10.1128%2FJB.00705-16&rft_id=info%3Apmid%2F27872182&rft.externalDocID=27872182 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9193&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9193&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9193&client=summon |